Abiopharma

(50% Neutral) FENNEC PHARMACEUTICALS INC. (FENC) Announces New Board Appointment

(50% Neutral) TRONOX HOLDINGS PLC (TROX) Files Form 8-K

(99% Neutral) REALPHA TECH CORP. (AIRE) Announces Business Combination

(80% Positive) STONERIDGE INC (SRI) Announces Business Combination

New Form SCHEDULE 13G - BRP Inc. <b>Filed:</b> 2026-04-28 <b>AccNo:</b> 0001422849-26-000044 <b>Size:</b> 7 KB

(50% Neutral) JEFFERIES FINANCIAL GROUP INC. (JEF) Announces Business Combination

Glassman Scott 🟡 adjusted position in 34.7K shares (6 derivative) of AIR INDUSTRIES GROUP (AIRI) at $12.20 Transaction Date: Apr 27, 2026 | Filing ID: 048605

(70% Positive) UNUM GROUP (UNMA) Reports Q2 2026 Financial Results

📋 Atlas Venture Opportunity Fund I, LP (Shareholder) plans to sell 47K shares of Dyne Therapeutics, Inc. (at $18.04 each, total $850K) Filed: Apr 28, 2026 | ID: 027983

Monteiro Mallika 🟢 acquired 2.9K shares (1 derivative) of CONSTELLATION BRANDS, INC. (STZ) Transaction Date: Apr 24, 2026 | Filing ID: 000004

Les stratégies européennes autour de ServiceNow mettent l’accent sur l’IA et la souveraineté

Europäische ServiceNow-Strategien konzentrieren sich auf KI und Souveränität

📋 Atlas Venture Fund XI, LP (Shareholder) plans to sell 119K shares of Dyne Therapeutics, Inc. (at $18.04 each, total $2.1M) Filed: Apr 28, 2026 | ID: 027982

Strickland Scott R. 🟡 adjusted position in 827 shares of WYNDHAM HOTELS & RESORTS, INC. (WH) at $85.88 Transaction Date: Apr 26, 2026 | Filing ID: 000054

📋 Atlas Venture Opportunity Fund II, LP (Shareholder) plans to sell 60K shares of Dyne Therapeutics, Inc. (at $18.04 each, total $1.1M) Filed: Apr 28, 2026 | ID: 027980